Filing Details
- Accession Number:
- 0001179110-18-009007
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-25 17:03:02
- Reporting Period:
- 2018-06-21
- Accepted Time:
- 2018-06-25 17:03:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1286370 | R Michael Minogue | C/O Abiomed, Inc., 22 Cherry Hill Drive Danvers MA 01923 | Chairman, President, Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock $.01 Par Value | Acquisiton | 2018-06-21 | 105,000 | $10.03 | 481,150 | No | 4 | M | Direct | |
| Common Stock $.01 Par Value | Disposition | 2018-06-21 | 2,400 | $434.47 | 478,750 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2018-06-21 | 7,984 | $435.63 | 470,766 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2018-06-21 | 5,481 | $436.76 | 465,285 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2018-06-21 | 8,009 | $437.88 | 457,276 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2018-06-21 | 30,611 | $438.65 | 426,655 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2018-06-21 | 24,497 | $439.74 | 402,168 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2018-06-21 | 6,696 | $440.60 | 395,472 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2018-06-21 | 3,634 | $441.75 | 391,838 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2018-06-21 | 1,293 | $442.75 | 390,545 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2018-06-21 | 3,300 | $443.77 | 387,245 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2018-06-21 | 4,325 | $445.17 | 382,920 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2018-06-21 | 1,605 | $445.92 | 381,315 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2018-06-21 | 4,165 | $447.01 | 377,150 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2018-06-21 | 1,000 | $450.06 | 376,150 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2018-06-21 | 105,000 | $0.00 | 105,000 | $10.03 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2011-06-03 | 2020-06-03 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock $.01 Par Value | 46,654 | Indirect | By Trust - A |
| Common Stock $.01 Par Value | 73,745 | Indirect | By Trust - B |
| Common Stock $.01 Par Value | 9,000 | Indirect | By Trust - C |
| Common Stock $.01 Par Value | 655 | Indirect | By Trust - D |
| Common Stock $.01 Par Value | 38,560 | Indirect | By Trust - E |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | $22.44 | 2013-05-22 | 2022-05-22 | 0 | 100,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $23.15 | 2014-05-14 | 2024-05-14 | 0 | 85,000 | Direct |
| Common Stock | Stock Option (right to buy) | $21.55 | 2015-05-14 | 2024-05-14 | 0 | 85,000 | Direct |
| Common Stock | Stock Option (right to buy) | $66.25 | 2016-05-13 | 2025-05-13 | 0 | 35,000 | Direct |
| Common Stock | Stock Option (right to buy) | $99.62 | 2017-05-24 | 2026-05-24 | 0 | 30,500 | Direct |
| Common Stock | Stock Option (right to buy) | $134.51 | 2018-05-15 | 2027-05-15 | 0 | 33,000 | Direct |
| Common Stock | Stock Option (right to buy) | $381.97 | 2019-05-16 | 2028-05-16 | 0 | 30,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2022-05-22 | 0 | 100,000 | Direct |
| 2024-05-14 | 0 | 85,000 | Direct |
| 2024-05-14 | 0 | 85,000 | Direct |
| 2025-05-13 | 0 | 35,000 | Direct |
| 2026-05-24 | 0 | 30,500 | Direct |
| 2027-05-15 | 0 | 33,000 | Direct |
| 2028-05-16 | 0 | 30,000 | Direct |
Footnotes
- These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
- Exercise of stock options pursuant to reporting owner's 10b5-1 plan.
- Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $434.0900 and $435.0000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $435.1400 and $436.0400. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $436.1800 and $437.1700. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $437.1900 and $438.1600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $438.1700 and $439.1400. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $439.1700 and $440.1600. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $440.1700 and $441.0800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $441.1800 and $442.1500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $442.3700 and $442.9000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $443.4300 and $444.0700. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $444.5400 and $445.5100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $445.6700 and $446.5000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $446.8300 and $447.2800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Billionaire Hedge Funds
